InvestorsHub Logo
Followers 6
Posts 637
Boards Moderated 0
Alias Born 08/22/2016

Re: optionking post# 40634

Wednesday, 09/19/2018 12:17:40 PM

Wednesday, September 19, 2018 12:17:40 PM

Post# of 49324
Per the Annual (10-K) report. Earliest time-frame is the first half of 2019 in the UK. subject to receiving adequate financing.

Today,
after deepening our scientific knowledge of the anti-cancer effects of pro-enzymes through our ongoing efforts with our
research
partners and strengthening our intellectual property portfolio by filing our patents in countries around the world, we
believe
we are ready to undertake human clinical trials and subject to receiving adequate financing, we hope to submit a clinical
trial application in the UK in the first half of 2019.